实用老年医学 ›› 2021, Vol. 35 ›› Issue (10): 1008-1011.doi: 10.3969/j.issn.1003-9198.2021.10.003
荣灿, 胡云
收稿日期:2021-08-10
出版日期:2021-10-20
发布日期:2021-10-13
通讯作者:
胡云,Email:huyundr@sina.com
作者简介:胡云 教授
Received:2021-08-10
Online:2021-10-20
Published:2021-10-13
中图分类号:
荣灿, 胡云. 瘦素抵抗与糖尿病相关研究进展[J]. 实用老年医学, 2021, 35(10): 1008-1011.
| [1] SALAZAR J, CHÁVEZ-CASTILLO M, ROJAS J, et al. Is "Leptin Resistance" another key resistance to manage type 2 diabetes?[J]. Curr Diabetes Rev, 2020, 16(7):733-749. [2] 杨晓宁, 张辰雨, 王炳蔚,等. 瘦素信号与瘦素抵抗机制研究进展[J]. 生理科学进展, 2015, 46(5):327-333. [3] SZCZESNA M, KIRSZ K, MISZTAL T, et al. Downregulation of LRb in VMH/DMH during the second half of gestation and upregulation of SOCS-3 in ARC in late-pregnant ewes - Implications for leptin resistance[J]. Gen Comp Endocrinol, 2019, 274:73-79. [4] DALAMAGA M, CHOU S H, SHIELDS K, et al. Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives[J]. Cell Metab, 2013, 18(1):29-42. [5] WU Q, CLARK M S, PALMITER R D. Deciphering a neuronal circuit that mediates appetite[J]. Nature, 2012, 483(7391):594-597. [6] QIU J, WAGNER E J, RØNNEKLEIV O K, et al. Insulin and leptin excite anorexigenic pro-opiomelanocortin neurones via activation of TRPC5 channels[J]. J Neuroendocrinol, 2018, 30(2):e12501. [7] MARROQUÍ L, GONZALEZ A, ÑECO P, et al. Role of leptin in the pancreatic β-cell: effects and signaling pathways[J]. J Mol Endocrinol, 2012, 49(1):R9-R17. [8] ROSENBAUM M, LEIBEL R L. Clinical review 107: role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin[J]. J Clin Endocrinol Metab, 1999, 84(6):1784-1789. [9] HAN Y M, KANG G M, BYUN K, et al. Leptin-promoted cilia assembly is critical for normal energy balance[J]. J Clin Invest, 2014, 124(5):2193-2197. [10] MYERS M G Jr, HEYMSFIELD S B, HAFT C, et al. Challenges and opportunities of defining clinical leptin resistance[J]. Cell Metab, 2012, 15(2):150-156. [11] LI J, WEI D, MCCRORY M A, et al. Human C-reactive protein impedes entry of leptin into the CNS and attenuates its physiological actions in the CNS[J]. Biochem J, 2016, 473(9):1215-1224. [12] HOWARD J K, CAVE B J, OKSANEN L J, et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3[J]. Nat Med, 2004, 10(7):734-738. [13] LUND I K, HANSEN J A, ANDERSEN H S, et al. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling[J]. J Mol Endocrinol, 2005, 34(2):339-351. [14] KWON O, KIM K W, KIM M S. Leptin signalling pathways in hypothalamic neurons[J]. Cell Mol Life Sci, 2016, 73(7):1457-1477. [15] ZHANG X Q, ZHANG G, ZHANG H, et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity[J]. Cell, 2008, 135(1):61-73. [16] OZCAN L, ERGIN A S, LU A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance[J]. Cell Metab, 2009, 9(1):35-51. [17] WILLIAMS K W, LIU T M, KONG X X, et al. Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis[J]. Cell Metab, 2014, 20(3):471-482. [18] OSEGBE I, OKPARA H, AZINGE E. Relationship between serum leptin and insulin resistance among obese Nigerianwomen[J]. Ann Afr Med, 2016, 15(1):14-19. [19] SHANKAR A, XIAO J. Positive relationship between plasma leptin level andhypertension[J]. Hypertension, 2010, 56(4):623-628. [20] ASFERG C, MØGELVANG R, FLYVBJERG A, et al. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study[J]. Am J Hypertens, 2010, 23(3):327-333. [21] GABRIELY I, MA X H, YANG X M, et al. Leptin resistance during aging is independent of fat mass[J]. Diabetes, 2002, 51(4):1016-1021. [22] WANG Z W, PAN W T, LEE Y, et al. The role of leptin resistance in the lipid abnormalities of aging[J]. FASEB J, 2001, 15(1):108-114. [23] MCNEELY M J, BOYKO E J, WEIGLE D S, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans[J]. Diabetes Care, 1999, 22(1):65-70. [24] MOONISHAA T M, NANDA S K, SHAMRAJ M, et al. Evaluation of leptin as a marker of insulin resistance in type 2 diabetes mellitus[J]. Int J Appl Basic Med Res, 2017, 7(3):176-180. [25] MITTENDORFER B, HOROWITZ J F, DEPAOLI A M, et al. Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes[J]. Diabetes, 2011, 60(5):1474-1477. [26] PANDEY N R, ZHOU X, QIN Z, et al. The LIM domain only 4 protein is a metabolic responsive inhibitor of protein tyrosine phosphatase 1B that controls hypothalamic leptin signaling[J]. J Neurosci, 2013, 33(31):12647-12655. [27] LANTZ K A, HART S G, PLANEY S L, et al. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice[J]. Obesity: Silver Spring, 2010, 18(8):1516-1523. [28] KOIZUMI M, TAKAGI-SATO M, OKUYAMA R, et al. In vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA in comparison of that of 2'-MOE-modified oligonucleotides[J]. Nucleic Acids Symp Ser: Oxf, 2007(51):111-112. [29] KIM Y W, KIM J Y, PARK Y H, et al. Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance[J]. Diabetes, 2006, 55(3):716-724. [30] CLEMMENSEN C, CHABENNE J, FINAN B, et al. GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet[J]. Diabetes, 2014, 63(4):1422-1427. [31] LUTZ T A. Amylinergic control of food intake[J]. Physiol Behav, 2006, 89(4):465-471. [32] TREVASKIS J L, COFFEY T, COLE R, et al. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms[J]. Endocrinology, 2008, 49(11):5679-5687. [33] MÜLLER T D, SULLIVAN L M, HABEGGER K, et al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21[J]. J Pept Sci, 2012, 18(6):383-393. [34] KARS M, YANG L, GREGOR M F, et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women[J]. Diabetes, 2010, 59(8):1899-1905. [35] XIAO C, GIACCA A, LEWIS G F. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans[J]. Diabetes, 2011, 60(3):918-924. |
| [1] | 王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006. |
| [2] | 顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029. |
| [3] | 周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069. |
| [4] | 刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437. |
| [5] | 刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437. |
| [6] | 杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437. |
| [7] | 王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437. |
| [8] | 唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259. |
| [9] | 代玲俐, 俞匀. 老年2型糖尿病病人估计肾小球滤过率与胰岛素抵抗及胰岛B细胞功能的相关性研究[J]. 实用老年医学, 2023, 37(12): 1219-1223. |
| [10] | 范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237. |
| [11] | 张贺成, 魏苏. 老年2型糖尿病病人血清铁蛋白水平与糖尿病足发生的相关性[J]. 实用老年医学, 2023, 37(11): 1111-1114. |
| [12] | 胡艳, 巫海娣, 王雪菲, 娄青林, 叶青, 顾刘宝, 戴静, 宋小波. 老年2型糖尿病病人糖尿病足风险评分与尿微量白蛋白/肌酐的相关性分析[J]. 实用老年医学, 2023, 37(11): 1134-1137. |
| [13] | 宗前兴, 莫永珍. 老年2型糖尿病健康状态分层框架的应用与研究进展[J]. 实用老年医学, 2023, 37(11): 1170-1175. |
| [14] | 张林英, 梅群超, 张炜琦, 胡一兰. 抗阻训练联合高乳蛋白营养在老年2型糖尿病伴肌少症病人中的应用研究[J]. 实用老年医学, 2023, 37(10): 995-999. |
| [15] | 刘倩慧, 姚子俊, 何玉立, 吴军. SGLT2i对老年糖尿病病人心血管保护机制的研究进展[J]. 实用老年医学, 2023, 37(10): 1064-1068. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
|
